Latest filing published 10 Sept 2026 for Metagenomi Therapeutics, Inc., €2,131.
All filings by Jian Irish on record concern Metagenomi Therapeutics, Inc. Over a trading history stretching from 1 April 2024 to 8 September 2026, the count stands at 11 filings.
Every open-market trade on record is a sale: 5 sales worth €19k. Other entries cover 5 share grants. In 2026 alone, the filings show no purchases and 2 sales.
The latest filing, published on 10 September 2026, reports an open-market sale of €2,131 in Metagenomi Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations